Bladder Cancer - Results from #20

Prognostic impact of combined loss of RB1, p53 and p21 in muscle-invasive bladder cancer. April 15, 2025

Integration and evaluation of implementation strategies to improve guideline-concordant bladder cancer surveillance: a prospective observational study. April 15, 2025

A Deep Learning Model to Predict Treatment Response and Recurrence from Whole Slide Images in Non-Muscle-Invasive Bladder Cancer - Expert Commentary April 14, 2025

Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active Surveillance. April 14, 2025

Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung Carcinoma. April 14, 2025

Deep learning-based model for prediction of early recurrence and therapy response on whole slide images in non-muscle-invasive bladder cancer: a retrospective, multicentre study. April 14, 2025

Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future Perspectives. April 11, 2025

Radical cystectomy mortality in older patients: a systematic review and meta-analysis. April 11, 2025

Estimating the Impact of Adjuvant Treatment With Nivolumab on Long-Term Survivorship Rates Compared With Surveillance in Muscle Invasive Urothelial Carcinoma: Mixture Cure Modeling Analyses of Disease-Free Survival From the Phase 3 CheckMate 274 Trial. April 11, 2025

Paradoxical Emergence of Cutaneous Squamous Cell Carcinoma During Pembrolizumab Treatment for Non-muscle Invasive Bladder Cancer and Subsequent Successful Therapeutic Adjustments. April 10, 2025

The Association between Tea Consumption and Bladder Cancer Risk Based on the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) International Consortium. April 10, 2025

Safety of nadofaragene firadenovec-vncg: review of data from phase 2 and phase 3 studies. April 9, 2025

Development and validation of interpretable machine learning models to predict distant metastasis and prognosis of muscle-invasive bladder cancer patients. April 9, 2025

BCG Treatment Response in Elderly Patients with Non-Muscle Invasive Bladder Cancer - Expert Commentary April 8, 2025

Evaluating the Efficacy and Safety of Durvalumab Plus Radiotherapy in Second-Line Treatment for Advanced Bladder Cancer. April 8, 2025

Perspective on the use of optics in bladder cancer detection and diagnosis. April 8, 2025

Clinical outcomes of BCG infections in patients undergoing intravesical immunotherapy for non-muscle-invasive bladder cancer: a systematic review and meta-analysis. April 7, 2025

Lines of Therapy for Locally Advanced/Metastatic Urothelial Carcinoma: The New Paradigm. April 7, 2025

Real-world avelumab first-line maintenance in advanced urothelial carcinoma: systematic review and meta-analysis. April 7, 2025

Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis. April 4, 2025

Page 2 of 535